LAGEVRIO (EUA)
  • LAGEVRIO (EUA)

  • QTY 40 • 200 MG • Capsule • Near 77381

MOLNUPIRAVIR (mol nue pir a vir) treats COVID-19. It is an antiviral medication. It may decrease the risk of developing severe symptoms of COVID-19. It may also decrease the chance of going to the hospital. This medication is not approved by the FDA. The FDA has authorized emergency use of this medication during the COVID-19 pandemic.

There is no Lifestyle Interaction information available for this medication.